Pasithea Therapeutics (KTTA) Return on Capital Employed (2021 - 2024)
Historic Return on Capital Employed for Pasithea Therapeutics (KTTA) over the last 4 years, with Q3 2024 value amounting to 0.92%.
- Pasithea Therapeutics' Return on Capital Employed fell 4600.0% to 0.92% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.92%, marking a year-over-year decrease of 4600.0%. This contributed to the annual value of 0.48% for FY2023, which is 2200.0% down from last year.
- According to the latest figures from Q3 2024, Pasithea Therapeutics' Return on Capital Employed is 0.92%, which was down 4600.0% from 0.91% recorded in Q2 2024.
- In the past 5 years, Pasithea Therapeutics' Return on Capital Employed registered a high of 0.12% during Q4 2021, and its lowest value of 0.92% during Q3 2024.
- Moreover, its 4-year median value for Return on Capital Employed was 0.36% (2023), whereas its average is 0.44%.
- Its Return on Capital Employed has fluctuated over the past 5 years, first plummeted by -1600bps in 2022, then plummeted by -5100bps in 2024.
- Over the past 4 years, Pasithea Therapeutics' Return on Capital Employed (Quarter) stood at 0.12% in 2021, then crashed by -131bps to 0.28% in 2022, then plummeted by -119bps to 0.62% in 2023, then plummeted by -49bps to 0.92% in 2024.
- Its Return on Capital Employed was 0.92% in Q3 2024, compared to 0.91% in Q2 2024 and 0.77% in Q1 2024.